Concepedia

Ken J. Butcher

KJ

Statistics

Publications

5

Citations

211

H-Index

5

Active since

1994

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

Ken J. Butcher is an author at Pfizer (United Kingdom) specializing in chemistry, drug discovery, and drug design.

Publications per year

1994–2017

5

Publications

5

Discovery of Clinical Candidate 4-[2-(5-Amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7

Nigel A. Swain, D. V. Batchelor, Serge Beaudoin et al. · Journal of Medicinal Chemistry · 2017 · 83 citations · Full text

, , +17

Discovery of Potent &amp; Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor for the Treatment of Thrombosis

Mark E. Bunnage, Julian Blagg, John Steele et al. · Journal of Medicinal Chemistry · 2007 · 42 citations · Full text

, , +14

Application of Barluenga Boronic Coupling (BBC) to the Parallel Synthesis of Drug‐like and Drug Fragment‐like Molecules

Shoko Nakagawa, Katie A. Bainbridge, Ken J. Butcher et al. · ChemMedChem · 2011 · 39 citations

, , +16

Carbamate esters: a simple, mild method of formation

Ken J. Butcher · Synlett · 1994 · 27 citations

, , +2

Aromatic amines as nucleophiles in the Bargellini reaction

Ken J. Butcher, Jenny Hurst · Tetrahedron Letters · 2009 · 20 citations

, , +4

1–5 of 5